HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OUTLOOK 2021

In Vivo’s annual showcase of special features and industry league tables for pharma, medtech and generics companies


VIEW 2021 RANKINGS

Latest from PR Newswire

Click here to access further cosmetics and dietary supplement news.

Health Explore this Topic

Set Alert for Health

Latest From Health

Alleged ‘Pink Tax’ Class Actions Against OTC Personal-Care Brands Moving Through Federal Courts

Walgreen Co. seeks to dismiss allegations in California’s Northern District that it unlawfully charges more for its OTC Hair Regrowth Treatment for women compared with a “functionally equivalent” offering for men. The suit follows “pink tax” litigation concerning Dove antiperspirants that defendants dismissed in July 2020, a decision affirmed by the Eighth Circuit in May.

United States Legal Issues

Bausch Health Has Full Plate While Trimming Debt, Setting Table For Bausch + Lomb Separation

Bausch Health says it’s continuing a recovery from the disaster previous management left, when the firm operated as Valeant Pharmaceuticals, even though it reported a $595m net loss for Q2. “We've been trying to solve this debt issue for the company,” says CEO Joseph Papa.

Business Strategies Consumer

Church & Dwight Cuts Outlook Due To Rising Costs, Adds Suppliers To Strengthen ‘Weak Links’

“We expect higher input costs and transportation costs to remain elevated for the rest of the year,” says CEO Matthew Farrell. Firms lowers full-year outlook for net sales growth from previous range of 5% to 6% to around 5%.

Dietary Supplements Sales & Earnings

Euro Results Round-Up: Alliance Pharma, Boiron And Ipsen

Round-up of Q2 and H1 financial results from three Europe-based consumer health companies: Alliance Pharma, Ipsen and Boiron.

Sales & Earnings OTC Drugs

Final Quarter Of P&G CEO Taylor’s Tenure Could Become Stormy With Headwinds From Rising Costs

P&G’s health care sector’s net sales grew 18% in its latest quarter. Continued growth across its sectors is critical in the face of expected $1.8bn in headwinds from commodity and freight costs in its FY2022.

Business Strategies Sales & Earnings

Restoring FTC Monetary Relief Authority: For Commission Members, Not One Size Fits All

House already passed legislation to amend Sec. 13(b) of FTC regulations and make explicit its authority to obtain injunctive and equitable relief in court, but differences in Democrat and Republican commission appointees' views on the authority was a key topic of discussion during a recent Energy and Commerce hearing.

Ad Complaints Consumer
See All

Beauty Explore this Topic

Set Alert for Beauty

Latest From Beauty

Alleged ‘Pink Tax’ Class Actions Against OTC Personal-Care Brands Moving Through Federal Courts

Walgreen Co. seeks to dismiss allegations in California’s Northern District that it unlawfully charges more for its OTC Hair Regrowth Treatment for women compared with a “functionally equivalent” offering for men. The suit follows “pink tax” litigation concerning Dove antiperspirants that defendants dismissed in July 2020, a decision affirmed by the Eighth Circuit in May.

United States Legal Issues

Stakeholders Vie For California DTSC's Ear On Hair Straighteners, With Priority Product Pick Looming

Industry and consumer advocates typically differ in their views on the California Department of Toxic Substances Control’s Safer Consumer Products work, and the DTSC’s investigation into hair-straightening chemicals is no exception. In any event, a Priority Product selection could be coming soon.

US States Cosmetic Ingredients

Mary CEO ‘Not Too Concerned’ About China’s CBD Cosmetics Ban

Mary Agrotechnologies CEO Frank Qin says he is “not too concerned” about China's recent  CBD cosmetics ban, despite his company's plans to build a 150,000 square-foot cultivation and extraction plant in Yunnan, with the aim of supplying the domestic CBD market and exporting overseas.

China Wellness

Church & Dwight Cuts Outlook Due To Rising Costs, Adds Suppliers To Strengthen ‘Weak Links’

“We expect higher input costs and transportation costs to remain elevated for the rest of the year,” says CEO Matthew Farrell. Firms lowers full-year outlook for net sales growth from previous range of 5% to 6% to around 5%.

Dietary Supplements Sales & Earnings

Final Quarter Of P&G CEO Taylor’s Tenure Could Become Stormy With Headwinds From Rising Costs

P&G’s health care sector’s net sales grew 18% in its latest quarter. Continued growth across its sectors is critical in the face of expected $1.8bn in headwinds from commodity and freight costs in its FY2022.

Business Strategies Sales & Earnings

Restoring FTC Monetary Relief Authority: For Commission Members, Not One Size Fits All

House already passed legislation to amend Sec. 13(b) of FTC regulations and make explicit its authority to obtain injunctive and equitable relief in court, but differences in Democrat and Republican commission appointees' views on the authority was a key topic of discussion during a recent Energy and Commerce hearing.

Ad Complaints Consumer
See All

Wellness Explore this Topic

Set Alert for Wellness

Latest From Wellness

Bausch Health Has Full Plate While Trimming Debt, Setting Table For Bausch + Lomb Separation

Bausch Health says it’s continuing a recovery from the disaster previous management left, when the firm operated as Valeant Pharmaceuticals, even though it reported a $595m net loss for Q2. “We've been trying to solve this debt issue for the company,” says CEO Joseph Papa.

Business Strategies Consumer

Sanofi India Offloads Nutraceuticals Business To Local Player

Sanofi India – in which France’s Sanofi S.A. holds a controlling 60% stake – is to divest its Nutraceuticals business in a deal worth around $80m. 

Deals India

Mary CEO ‘Not Too Concerned’ About China’s CBD Cosmetics Ban

Mary Agrotechnologies CEO Frank Qin says he is “not too concerned” about China's recent  CBD cosmetics ban, despite his company's plans to build a 150,000 square-foot cultivation and extraction plant in Yunnan, with the aim of supplying the domestic CBD market and exporting overseas.

China Wellness

Investment Group Focused On Natural Wellness Acquires Plant-Based Protein Pioneer Vega

WM Partners acquires Vega plant-based nutrition brand from Danone with plans to leverage its operational experience to grow the brand and tap Vega’s distribution to expand market for its existing portfolio of brands.

M & A Dietary Supplements

Church & Dwight Cuts Outlook Due To Rising Costs, Adds Suppliers To Strengthen ‘Weak Links’

“We expect higher input costs and transportation costs to remain elevated for the rest of the year,” says CEO Matthew Farrell. Firms lowers full-year outlook for net sales growth from previous range of 5% to 6% to around 5%.

Dietary Supplements Sales & Earnings

Euro Results Round-Up: Alliance Pharma, Boiron And Ipsen

Round-up of Q2 and H1 financial results from three Europe-based consumer health companies: Alliance Pharma, Ipsen and Boiron.

Sales & Earnings OTC Drugs
See All

Market Intelligence Explore this Topic

Set Alert for Market Intelligence

Latest From Market Intelligence

Mary CEO ‘Not Too Concerned’ About China’s CBD Cosmetics Ban

Mary Agrotechnologies CEO Frank Qin says he is “not too concerned” about China's recent  CBD cosmetics ban, despite his company's plans to build a 150,000 square-foot cultivation and extraction plant in Yunnan, with the aim of supplying the domestic CBD market and exporting overseas.

China Wellness

Health And Wellness Weekly Trademark Review 27 July, 2021

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Dietary Supplements OTC Drugs

Cosmetic And Personal Care Trademark Review 27 July, 2021

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Commercial Cosmetics
See All
UsernamePublicRestriction

Register